Axe Physiopathologie Ostéo-articulaire
PUBLICATIONS ANTÉRIEURES
2005
Boire G, Cossette P, de Brum-Fernandes AJ, Liang P, Niyonsenga T, Zhou ZJ, Carrier N, Daniel C, Menard HA. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis., Arthritis Res Ther. 2005;7(3):R592-603.

Gallant MA, Samadfam R, Hackett JA, Antoniou J, Parent JL, de Brum-Fernandes AJ. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors., J Bone Miner Res. 2005 Apr;20(4):672-81.

Hamelin E, Theriault C, Laroche G, Parent JL. The intracellular trafficking of the G protein-coupled receptor TPbeta depends on a direct interaction with Rab11., J Biol Chem. 2005 Oct 28;280(43):36195-205.

Laroche G, Lepine MC, Theriault C, Giguere P, Giguere V, Gallant MA, de Brum-Fernandes A, Parent JL. Oligomerization of the alpha and beta isoforms of the thromboxane A2 receptor: relevance to receptor signaling and endocytosis., Cell Signal. 2005 Nov;17(11):1373-83.

Laroche G, Rochdi MD, Laporte SA, Parent JL. Involvement of actin in agonist-induced endocytosis of the G protein-coupled receptor for thromboxane A2: overcoming of actin disruption by arrestin-3 but not arrestin-2., J Biol Chem. 2005 Jun 17;280(24):23215-24.

Perreault J, Noel JF, Briere F, Cousineau B, Lucier JF, Perreault JP, Boire G. Retropseudogenes derived from the human Ro/SS-A autoantigen-associated hY RNAs., Nucleic Acids Res. 2005 Apr 7;33(6):2032-41.

Roux S, Lambert-Comeau P, Saint-Pierre C, Lepine M, Sawan B, Parent JL. Death receptors, Fas and TRAIL receptors, are involved in human osteoclast apoptosis., Biochem Biophys Res Commun. 2005 Jul 22;333(1):42-50.

Liang P, Hoffman GS. Advances in the medical and surgical treatment of Takayasu arteritis. Cur Opin Rheumatol 2005, 17 (1) : 16-24.


 2004
Battersby S, Critchley HO, de Brum-Fernandes AJ, Jabbour HN. Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle, Reproduction. 2004 Jan;127(1):79-86.

Boire G, Noël JF, Perreault J, Brière F, Abou-Elela S, Chabot B, Wellinger R, Perreault JP, Cousineau B. The expansion of hY RNA pseudogenes in primates: mechanisms and potential consequences. 4th International Conference on Sex Hormones, Pregnancy and the Rheumatic Diseases, 20-22 septembre 2004, Stresa, Italie. Lupus 13:S9; 756, 2004.

Boire G, Cossette P, De Brum-Fernandes AJ, Hercelin D, Liang P, Myhal D, Roux S, Nyonsenga T, Gingras M, Daniel C, Beauchemin J, Deschênes I, Ménard HA. Autoantibodies as prognostic markers of persistence and of severity at 18, 30 and 42 months in early polyarthritis (EPA) patients. J Rheumatol 31:1427, 2004.

Boire G, Cabana F, de Brum Fernandes AJ, Hercelin D, Liang P, Robindaine J, Roux S. Improving treatment of osteoporosis following fragility hip fractures: Assessment of 2 interventions. ACR 68th National Scientific Meeting, October 16-21, 2004, San Antonio, Texas. Arthritis and Rheumatism 50 (Suppl.) :S503, 2004.

Boire G, Cossette P, Daniel C, de Brum Fernandes AJ, Hercelin D, Liang P, Ménard HA, Niyonsenga T, Roux S. Stability over time of rheumatoid-arthritis associated antibodies in patients with polyarthritis of recent onset. ACR 68th National Scientific Meeting, October 16-21, 2004, San Antonio, Texas. Arthritis and Rheumatism 50 (Suppl.):S675, 2004.

Brière F, Chabot B, Klarskov K, Boire G. Proteins binding to hY3 RNA and to hY3-containing RNPs. 4th International Conference on Sex Hormones, Pregnancy and the Rheumatic Diseases, 20-22 septembre 2004, Stresa, Italie. Lupus 13:S9; 756, 2004.

Bykerk VP, Baron M, Boire G, Haraoui B, Khraishi M, LeClercq S, Pope JE, Keystone EC. Déclaration consensuelle canadienne sur le traitement optimal dela polyarthrite rhumatoïde précoce. Journal de la Société canadienne de rhumatologie 14 :11-13, 2004.

Fortier I, Gallant MA, Hackett JA, Patry C, de Brum-Fernandes AJ. Immunolocalization of the prostaglandin E2 receptor subtypes in human bone tissue: differences in foetal, adult normal, osteoporotic and pagetic bone, Prostaglandins Leukot Essent Fatty Acids. 2004 May;70(5):431-9.

Geoffroy V, Marty-Morieux C, Le Goupil N, Clement-Lacroix P, Terraz C, Frain M, Roux S, Rossert J, de Vernejoul MC. In vivo inhibition of osteoblastic metalloproteinases leads to an increased trabecular bone mass, J Bone Miner Res 2004, 19(5) ; 811- 822.

Giguere V, Gallant MA, de Brum-Fernandes AJ, Parent JL. Role of extracellular cysteine residues in dimerization/oligomerization of the human prostacyclin receptor, Eur J Pharmacol. 2004 Jun 21;494(1):11-22.

Gottenberg JE, Roux S, Assayag P, Clerc D, Mariette X. Specific cardiomyopathy in lupus patients: report of three cases, Joint Bone Spine 2004, 71: 66-69.

Hanly JG for the Canadian Council of Academic Rheumatologists (including Boire G) Ostéo Physician resources and postgraduate training in Canadian academic rheumatology Centers: A five-year prospective study. Journal of Rheumatology 31 :1200-05, 2004

Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis, Arthritis Rheum 50:2296-2304, 2004.

Lavie F, Miceli-Richard C, Quillard J, Roux S, Leclerc P, Mariette X. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome, J Pathol. 2004 Apr;202(4):496-502.

Liang P. L'arthrose : articulez le traitement, Le Clinicien 19:85-90, 2004.

Liang P, Tan-Ong M, Hoffman GS. Takayasu’s arteritis: Vascular interventions and outcomes, J Rheumatol 31:102-106, 2004.

Néron S, Racine C, Boire G, Fernandes A, Jacques a. In vitro characterization of IVIg effects on B lymphocytes from SLE patients following CD40 stimulation. In Second International Conference on B cells & autoimmunity: new concepts & therapeutic perspectives. 15-18 juillet 2004, Québec, Canada.

Rochdi MD, Laroche G, Dupre E, Giguere P, Lebel A, Watier V, Hamelin E, Lepine MC, Dupuis G, Parent JL. Nm23-H2 interacts with a G protein-coupled receptor to regulate its endocytosis through an Rac1-dependent mechanism, J Biol Chem. 2004 Apr 30;279(18):18981-9.

Roux S. Avancées dans l’ostéoporose, Abstract-Rhumatologie 2004, n°248 : 11-13.

Roux S, Baudoin C, Boute D, Brazier M, de La Guerronière Y, de Vernejoul MC. Biological effects of drinking-water mineral composition on calcium balance and bone remodeling markers, Journal of Nutrition, Health & Aging 2004, 8(5) :380-4.

Roux S, Mariette X. The high rate of bone resorption in multiple myeloma is due to RANK (receptor activator of nuclear factor-kappaB) and RANK Ligand expression, Leuk Lymphoma. 2004 Jun;45(6):1111-8. Review.

Sarrazin P, Hackett JA, Fortier I, Gallant MA, de Brum-Fernandes A. Role of EP3 and EP4 prostaglandin receptors in reorganization of the cytoskeleton in mature human osteoclasts, J Rheumatol. 2004 Aug;31(8):1598-606.

Theriault C, Rochdi MD, Parent JL. Role of the Rab11-associated intracellular pool of receptors formed by constitutive endocytosis of the beta isoform of the thromboxane A2 receptor (TP beta), Biochemistry. 2004 May 18;43(19):5600-7.


2003
Deschênes I, Dion L, Beauchesne C, Fernandes A. Kaposi’s sarcoma following immune suppressive therapy for Wegener’s granulomatosis. , J Rheumatol, 30:622-624, 2003.

Dupré DJ, Chen Z, Le Gouill C, Thériault C, Parent JL, Rola-Pleszczynski M and Stankova J. Trafficking, Ubiquitination and Down-regulation of the human Platelet-Activating Factor Receptor, J Biol Chem, 278:48228-48235, 2003.

Mariette X, Roux S, Zhang J, Bengoufa D, Zhou T, Kimberly R. The level of BLyS (BAFF) correlates with the titer of autoantibodies in human Sjögren’s syndrome, Ann Rheum Dis, 62(2):168-171, 2003.

Peters RR, Krepsky PB, Siqueira-Junior JM, Rocha JCS, Bezerra MM, Ribeiro RA, de Brum-Fernandes AJ, Farias MR, Castro da Rocha FA, Ribeiro-do-Valle RM. Nitric oxide and cyclooxygenase may participate in the analgesic and anti-inflammatory effect of the cucurbitacins fraction from Wilbrandia ebracteata., Life Sci, 73:2185-97, 2003.

Rochdi MD, Parent JL. Galphaq-coupled receptor internalization specifically induced by Galphaq signaling. Regulation by EBP50, J Biol Chem, May 16;278(20):17827-37, 2003.

Roux S, Bergot C, Frija J, Brouet JC, Fermand JP, X. Mariette X. Bone mineral density in patients with myeloma in prolonged remission, J Bone Min Res, 18 (2) : 231- 236, 2003.

Roux S. Les nouveaux facteurs impliqués dans la résorption osseuse. Éditorial. , Réflexions Rhumatologiques, 7 (n°57) : 3, 2003.

Roux S. Le système RANKL-RANK et OPG : Ostéopathies métaboliques et génotypiques, Ostéolyse maligne, Résorption osseuse sous-chondrale de la PR., Réflexions Rhumatologiques, 7 (n°57) : 7-22, 2003.

Siqueira-Junior JM, Peters RR, de Brum-Fernandes AJ, Ribeiro-do-Valle RM. Effects of valeryl salicylate, a COX-1 inhibitor, on models of acute inflammation in mice., Pharmacol Res, 48:437-43, 2003.

Sneddon WB, Syme CA, Bisello A, Magyar CE, Rochdi MD, Parent JL, Weinman EJ, Abou-Samra AB, Friedman PA. Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50), J Biol Chem, Oct 31;278(44):43787-96, 2003.


2002
Hoffman GS, Calabrese LH, Liang P . The treatment of systemic vasculitides with biologic agents. In: Lipsky PE, Smolen JS, eds. Biological therapy in rheumatology, Martin Dunitz limited: London, , 2002.

Hoffman GS, Tan-Ong M, Liang P . Anti-tumor necrosis factor (anti_TNF) therapy in Takyasu’s arteritis (TA) resistant to conventional therapy, Cleveland Clinic Journal of Medicine, 69 (suppl II): SII-182-183, 2002.

Mariette X, Sibilia J, Roux S, Meignin V, Janin A. A new defensive mechanism to prevent apoptosis in salivary ductal cells from patients with Sjogren's syndrome: overexpression of p53 and p21, Rheumatology (Oxford), 41: 96- 99, 2002.

Pérodin J, Deraët M, Auger-Messier M, Boucard AA, Rihakova L, Parent JL, Leduc R, Guillemette G, Escher E . Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor, Biochemistry, 41, 14348-14356, 2002.

Rochdi MD, Watier V, La Madeleine C, Nakata H, Kozasa T, Parent JL. Regulation of GTP-binding protein ?q (G?q) signaling by the ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50), Journal of Biological Chemistry, 277, 40751-40759, 2002.

Roux S. Le système RANKL-RANK et OPG dans l'ostéolyse maligne, La Lettre du Rhumatologue, 284 : 6-10, 2002.

Roux S. Le Récepteur du calcium: Physiopathologie et applications thérapeutiques, Synoviale, n°108: 33- 39, 2002.

Roux S, Amazit L, Meduri G, Guiochon-Mantel A, Milgrom E, Mariette X. RANK (Re-ceptor Activator of Nuclear Factor ?B) and RANKL are expressed in giant cell tumors of bone, Am J Clin Pathol, 117: 210- 216, 2002.

Roux S, Lasbleiz S, Bardin TH. Mécanismes et évaluation de la résorption sous-chondrale dans la polyarthrite rhumatoïde In : de Sèze S, Ryckewaert A, Kahn MF, Kuntz D, Meyer O, Bardin Th, Orcel Ph, Guérin Cl., L'Actualité Rhumatologique, Paris, Elsevier Editions. , p22-41, 2002.

Roux S, Meignin V, Quillard J, Guiochon-Mantel A, Fermand JP, Milgrom E, Mariette X. RANK (receptor activator of NF-?B) and RANK Ligand expression in multiple myeloma, Br J Haematol, 117: 86- 92, 2002.

Roux S, Orcel Ph. Mise au point sur l'Ostéoprotégérine, Synoviale, n°118 :20-25, 2002.

Tan-Ong M, Liang P, Hoffman GS . Outcomes of vascular intervention (surgery and angioplasty) in patients with Takayasu arteritis, Cleveland Clinic Journal of Medicine, 69 (suppl II): SII-188-189, 2002.